Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1β-methyl group and C-2 side chain

Journal of Antibiotics

Volumn 50, Issue 2, 1997, Pages 162-168

  Kanazawa, Katsunori ^a   Nouda, Hiroshi ^a   Sunagawa, Makoto ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CATION; DRUG DERIVATIVE; MEROPENEM; METHYL GROUP; PANIPENEM; PENICILLIN BINDING PROTEIN;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG PROTEIN BINDING; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030995146     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.50.162     Document Type: Article

References (27)

1. MURPHY, T. F. & M. A. APICELLA: Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection. Rev. Infect. Dis. 9: 1-15, 1987
2. SUMITA, Y.; S. MITSUHASHI & M. INOUE: In vitro antibacterial activity of meropenem, a new carbapenem antibiotic. Chemotherapy (Tokyo) 40 (Suppl. 1): 1-15, 1992
3. DEGUCHI, K.; M. KOGUCHI, Y. SUZUKI, S. TANAKA, S. FUKAYAMA, R. ISHIHARA, S. ODA, Y. NAKANE & T. FUKUMOTO: Antimicrobial activities of meropenem against clinically isolated strains. Jap. J. Antibiotics 49: 175-193, 1996
4. JORGENSEN, J. H.; L. A. MAHER & A. W. HOWELL: Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with β-lactamase- and non-enzyme-mediated resistance to ampicillin. Antimicrob. Agents Chemother. 35: 600-602, 1991
5. POWELL, M.; P. SEETULSINGH & J. D. WILLIAMS: In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other β-lactams, chloramphenicol and ciprofloxacin. J. Antimicrob. Chemother. 24 (Suppl. A): 175-181, 1989
6. YEO, S. F. & D. M. LIVERMORE: Comparative in-vitro activity of biapenem and other carbapenems against Haemophilus influenzae isolates with known resistance mechanisms to ampicillin. J. Antimicrob. Chemother. 33: 861-865, 1994
7. SUMITA, Y.; H. YAMAGA & M. SUNAGAWA: The effect of 1β-methyl substituent and the basicity in C-2 side chain in carbapenem antibiotics on the activity against Pseudomonas aeruginosa oprD2 and nalB mutants. J. Antibiotics 48: 89-91, 1995
8. SUNAGAWA, M.; H. MATSUMURA, A. SASAKI, H. YAMAGA, Y. SUMITA & H. NOUDA: Structure-activity relationship of 1β-methyl-carbapenem to its antibacterial activity: effect of the C-2 side chain and the 1β-methyl group. J. Antibiotics 49: 1175-1178, 1996
9. SUNAGAWA, M.; H. MATSUMURA, T. INOUE, M. FUKASAWA & M. KATO: A novel carbapenem antibiotic, SM-7338 structure-activity relationships. J. Antibiotics 43: 519-532, 1990
10. SHIBATA, T. & Y. SUGIMURA: Synthetic studies of 1-β-methylcarbapenem antibiotics. J. Antibiotics 42: 374-381, 1989
11. SUNAGAWA, M.; H. MATSUMURA, T. INOUE, M. FUKASAWA & M. KATO: A new series of carbapenem antibiotics with 5′-substituted pyrrolidinylthio group at C-2 position. J. Antibiotics 44: 459-462, 1991
12. NAGAO, Y.; Y. NAGASE, T. KUMAGAI, H. MATSUNAGA, T. ABE, O. SHIMADA, T. HAYASHI & Y. INOUE: β-Lactams. 3. Asymmetric total synthesis of new non-natural 10-methylcarbapenems exhibiting strong antimicrobial activities and stability against human renal dehydropeptidase-I. J. Org. Chem. 57: 4243-4249, 1992
13. MAKOVER, S. D.; R. WRIGHT & E. TELEP: Penicillin-binding proteins in Haemophilus influenzae. Antimicrob. Agents Chemother. 19: 584-588, 1981
14. IGARASHI, J.; T. NISHIMURA, A. SASAKI & M. SUNAGAWA: Conformational analysis of meropenem and desmethyl meropenem: the effect of 1β-methyl group on carbapenem antibiotics. Bioorg. Med. Chem. Lett. (in press)
15. NOUDA, H.; H. MATSUMURA, T. TANIO & M. SUNAGAWA: Structural features of carbapenem compounds for nephrotoxicity: effect of C-2 side chain. J. Antibiotics 49: 603-606, 1996
16. MASUYOSHI, S.; S. MITSUHASHI, M. INOUE, M. HIRAOKA & H. MATSUI: In vitro and in vivo antibacterial activity and β-lactamase atability of cefepime, a new parenteral cephalosporin. Chemotherapy (Tokyo) 39 (Suppl. 2): 1-14, 1991
17. NISHINO, T.; M. OTSUKI, S. MASUYOSHI, H. MITSUNO & H. HIRAOKA: In vitro and in vivo antibacterial activities of cefepime (BMY-28142). Chemotherapy (Tokyo) 39 (Suppl. 2): 59-67, 1991
18. NEU, H. C.: Structure-activity relations of new β-lactam compounds and in vitro activity against common bacteria. Rev. Infect. Dis. 5 (Suppl. 2): 319-337, 1983
19. THORNSBERRY, C.: Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria. Am. J. Med. 79 (Suppl. 2A): 14-20, 1985
20. SUNAGAWA, M.; H. YAMAGA, H. SHINAGAWA, H. HOUCHIGAI & Y. SUMITA: Synthesis and biological properties of a new series of anti-MRSA β-lactams; 2-(thiazol-2′-ylthio) carbapenems. Bioorg. Med. Chem. Lett. 4: 2793-2798, 1994
21. MALOUIN, F.; T. R. PARR, Jr. & L. E. BRYAN: Identification of a group of Haemophilus influenzae penicillin-binding proteins that may have complementary physiological roles. Antimicrob. Agents Chemother. 34: 363-365, 1990
22. MALOUIN, F. & L. E. BRYAN: Haemophilus influenzae penicillin-binding proteins 1a and 3 possess distinct and opposite temperature-modulated penicillin-binding activities. Antimicrob. Agents Chemother. 32: 498-502, 1988
23. MENDELMAN, P. M. & D. O. CHAFFIN: Penicillin-binding proteins 4 and 5 of Haemophilus influenzae are involved in cell wall incorporation. FEMS Microbiol. Lett. 48: 239-242, 1987
24. SHIMIZU, M.; T. TAKATA, S. MASUYOSHI & T. YOSHIDA: Antibacterial activity, bactericidal effect and β-lactamase stability of CDTR, and its binding affinity to PBPs against clinical isolate of Haemophilus influenzae. Jpn. J. Chemother. 43: 815-820, 1995
25. CLAIROUX, N.; M. PICARD, A. BROCHU, N. ROUSSEAU, P. GOURDE, D. BEAUCHAMP, T. R. PARR, Jr., M. G. BERGERON & F. MALOUIN: Molecular basis of the non-β-lactamase-mediated resistance to β-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob. Agents Chemother. 36: 1504-1513, 1992
26. PARR, T. R., Jr. & L. E. BRYAN: Mechanism of resistance of an ampicillin-resistant, β-lactamase-negative clinical isolate of Haemophilus influenzae type b to β-lactam antibiotics. Antimicrob. Agents Chemother. 25: 747-753, 1984
27. GEORGOPAPADAKOU, N. H.: Penicillin-binding proteins and bacterial resistance to β-lactams. Antimicrob. Agents Chemother. 37: 2045-2053, 1993